UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010734
Receipt number R000012546
Scientific Title Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients?
Date of disclosure of the study information 2013/05/16
Last modified on 2014/10/04 20:24:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients?

Acronym

The dose of rocuronium for safe tracheal intubation

Scientific Title

Can neuromuscular monitoring at the adductor pollicis detect timing for safe trachealintubation in elderly patients?

Scientific Title:Acronym

The dose of rocuronium for safe tracheal intubation

Region

Japan


Condition

Condition

Surgical patients requiring general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For safe tracheal intubation, sufficient depth of neuromuscular block of the masseter, laryngeal muscles and diaphragm is needed. The responses of the adductor pollicis muscle (APM) to the ulnar nerve stimulation are usually observed during induction of anesthesia and used to determine the timing of tracheal intubation. However, movement of the vocal cord and cough reflex are frequently seen during laryngoscopy and tracheal intubation even after obtaining complete neuromuscular block at the APM.
We will examine a correlation between the dose of rocuronium and intubating conditions and hope to contribute to safe tracheal intubation in elderly patients.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

onset time of rocuronium-induced neuromuscular block and evaluation of intubating conditions.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A correlation between onset of the action of rocuronium 0.6 mg/kg and intubating conditions will be analyzed.

Interventions/Control_2

A correlation between onset of the action of rocuronium 1mg/kg and intubating conditions will be analyzed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients having allergic factors to neuromuscular blocking agents
2) ASA risk 4 and above
3) BMI 30 and above or below 18.5
4)Patients having hepatic and renal disorders

Key exclusion criteria

1)Patients having allergic factors to neuromuscular blocking agents
2)ASA risk 4 and above
3)BMI 30 and above or below 18.5
4)Patients having hepatic and renal disorders

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satomi Yamamoto

Organization

Nihon University of Medicine

Division name

Department of Anesthsiology

Zip code


Address

30-1 Oyaguchi-Kmimachi Itabashi-Ku Tokyo

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Nihon University of Medicine

Division name

Department of Anesthsiology

Zip code


Address

30-1 Oyaguchi-Kmimachi Itabashi-Ku Tokyo

TEL


Homepage URL


Email



Sponsor or person

Institute

Nihon University of Medicine department of Anesthsiology

Institute

Department

Personal name



Funding Source

Organization

Nihon University of Medicine department of Anesthsiology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 05 Day

Date of IRB


Anticipated trial start date

2013 Year 04 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 05 Month 16 Day

Last modified on

2014 Year 10 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012546


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name